Cancer in Children
On this page
Overview
Cancer death rates for children have fallen sharply in the United States thanks to the remarkable advances in the treatment of leukemia and other cancers. The Children's Cancer and Blood Disease Program at UCSF Benioff Children's Hospitals is an international leader in the treatment of cancer and blood diseases. Because childhood cancer differs from adult cancer in the way it emerges and develops, our programs are designed specifically for children. With this expertise, many childhood cancers are cured and the outlook is good for many of our young patients.
UCSF Benioff Children's Hospitals medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your child's doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your child's provider.
Awards & achievements
Clinical trials
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade GliomaOpens in a new window
This study aims to evaluate the efficacy of Laser Interstitial Thermal Therapy (LITT) in treating recurrent or progressive, low-grade gliomas (LGG) in pediatric, adolescent and young adult patients.PediRISE FeasibilityOpens in a new window
The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program...Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid CancerOpens in a new window
Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy...
Research initiatives
New Approaches to Neuroblastoma Therapy ConsortiumOpens in a new window
NANT is an international consortium that runs early-phase clinical trials, translating laboratory discoveries into new precision therapies for children with high-risk or relapsed neuroblastoma.




